SS&C GlobeOp Forward Redemption Indicator: October Notifications 1.62%

WINDSOR, Conn.--(BUSINESS WIRE)--Oct 21, 2026--

SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced the SS&C GlobeOp Forward Redemption Indicator for October 2026 measured 1.62%, down from 2.02% in September.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261021210428/en/

“SS&C GlobeOp’s Forward Redemption Indicator declined to 1.62% for October 2026, which was below the five-year average of 2.06%,“ said Bill Stone, Chairman and Chief Executive Officer of SS&C Technologies. “With significant uncertainties ahead from the upcoming U.S. midterm elections, rising inflation, and the financing of the AI buildout, allocators continue to favor hedge funds to manage drawdowns and improve risk-adjusted returns.”

The SS&C GlobeOp Forward Redemption Indicator represents the sum of forward redemption notices received from investors in hedge funds administered by SS&C GlobeOp on the SS&C GlobeOp platform, divided by the AuA at the beginning of the month for SS&C GlobeOp fund administration clients on the SS&C GlobeOp platform. Forward redemptions as a percentage of SS&C GlobeOp's assets under administration on the SS&C GlobeOp platform have trended significantly lower since reaching a high of 19.27% in November 2008. The next publication date is November 20, 2026.

Published on the 15th business day of the month, the SS&C GlobeOp Forward Redemption Indicator presents a timely and accurate view of the redemption pipeline for investors in hedge funds on the SS&C GlobeOp administration platform. Movements in the Indicator reflect investor confidence in their allocations to hedge funds. Indicator data is based on actual investor redemption notifications received. Unlike subscriptions, redemption notifications are typically received 30-90 days in advance of the redemption date. Investors may, and sometimes do, cancel redemption notices. In addition, the establishment and enforcement of redemption notices may vary from fund to fund.

SS&C GlobeOp Hedge Fund Performance Index

SS&C GlobeOp Capital Movement Index

SS&C GlobeOp Forward Redemption Indicator

About the SS&C GlobeOp Hedge Fund Index ®

The SS&C GlobeOp Hedge Fund Index (the Index) is a family of indices published by SS&C GlobeOp. A unique set of indices by a hedge fund administrator, it offers clients, investors and the overall market a welcome transparency on liquidity, investor sentiment and performance. The Index is based on a significant platform of diverse and representative assets.

The SS&C GlobeOp Capital Movement Index and the SS&C GlobeOp Forward Redemption Indicator provide monthly reports based on actual and anticipated capital movement data independently collected from all hedge fund clients for whom SS&C GlobeOp provides administration services on the SS&C GlobeOp platform.

The SS&C GlobeOp Hedge Fund Performance Index is an asset-weighted benchmark of the aggregate performance of funds for which SS&C GlobeOp provides monthly administration services on the SS&C GlobeOp platform. Flash estimate, interim and final values are provided, in each of three months respectively, following each business month-end.

While individual fund data is anonymized by aggregation, the SS&C GlobeOp Hedge Fund Index data will be based on the same reconciled fund data that SS&C GlobeOp uses to produce fund net asset values (NAV). Funds acquired through the acquisition of Citi Alternative Investor Services are integrated into the index suite starting with the January 2017 reporting periods. SS&C GlobeOp’s total assets under administration on the SS&C GlobeOp platform represent approximately 10% of the estimated assets currently invested in the hedge fund sector. The investment strategies of the funds in the indices span a representative industry sample. Data for middle and back office clients who are not fund administration clients is not included in the Index, but is included in the Company’s results announcement figures.

About SS&C Technologies

SS&C is a leading provider of mission-critical, AI-powered technology and services empowering financial services and healthcare organizations to work smarter, faster, and securely. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices worldwide. More than 23,000 financial services and healthcare organizations, from the world's largest companies to small and mid-market firms, rely on SS&C for expertise, scale and technology.

Additional information about SS&C (Nasdaq: SSNC) is available at www.ssctech.com.

Follow SS&C on X, LinkedIn and Facebook.

SS&C GlobeOp Forward Redemption Indicator

NEW YORK (AP) — The NFL welcomes an investigation into the Philadelphia Eagles’ handling of Jalen Hurts’ blood clots after the players’ union asked for one, Commissioner Roger Goodell said Wednesday.

Goodell said in his news conference at the end of the NFL’s annual fall meeting that Dr. Allen Sills, the league's chief medical officer, has gone through the steps that were followed and added that the union had a right to call for a review.

“Obviously, there was a medical evaluation, and I think our protocols were incredibly good there,” Goodell said. “The protocols were followed. Our process is to make sure that’s the case, and our chief medical officer has gone through that, so we’re comfortable that what we’ve seen in the protocols have happened.”

Sills on Tuesday offered a passionate defense of the Eagles medical staff. The NFL said officials were in touch with team doctors and trainers, as well as the Cleveland Clinic in London.

League executive vice president Jeff Miller said officials had a good sense of the course of events. He disputed a report that Hurts was awake for more than 30 hours before playing against Jacksonville on Oct. 11, saying that the QB returned to the hotel and slept for roughly seven or eight hours.

Hurts is on injured reserve and expected to miss the rest of the season after a blood clot in his left calf traveled to his lungs. The Eagles and agent Nicole Lynn said Monday that Hurts has deep vein thrombosis and bilateral pulmonary embolisms.

Goodell downplayed the role that international travel may have had in the situation.

“The most important thing here is Jalen’s health, ultimately, and the future of him,” Goodell said. “He’s a wonderful young man: not just a great player, but he’s someone we all care deeply about. I’m more worried about his health, ultimately, but the protocols were followed.”

Sills said Tuesday the decision to allow someone with a blood clot to fly depends on several variables, including the location, a patient's history and more.

“What I can tell you is expert people getting a lot of opinions,” Sills said. "This isn’t just one doctor saying yay or nay. You’re going to poll a panel of experts both within the team and outside the team to get the best judgment and experience with a particular condition.”

See AP’s full NFL coverage here

NFL commissioner Roger Goodell speaks during a news conference at the NFL owners' meetings Wednesday, Oct. 21, 2026, in New York. (AP Photo/Yuki Iwamura)

Jacksonville Jaguars defensive tackle Arik Armstead (91) speaks to NFL commissioner, Roger Goodell during the warm-up before an NFL football game against Philadelphia Eagles in London, Sunday, Oct. 11, 2026. (AP Photo/Ian Walton)

Philadelphia Eagles quarterback Jalen Hurts (1) attends a press conference after an NFL football game against Jacksonville Jaguars in London, Sunday, Oct. 11, 2026. (AP Photo/Alastair Grant)

NFL commissioner Roger Goodell speaks during a news conference at the NFL owners' meetings Wednesday, Oct. 21, 2026, in New York. (AP Photo/Yuki Iwamura)